WOBURN, Mass., Aug. 16, 2012 /PRNewswire/ -- CBI recently added a new panelist, Lisa Delancy PharmD, JD, MBA formerly Director, Pharmacy Rebate Contracting and Network with WellCare Health Plans, to the 9th Annual Forum on Formulary and Reimbursement Strategies agenda.
This September 20-21, attendees will come together during the Payer Panel Discussion, What Payers Want - Dive Deep into the Payer Decision-Making Process, for an open dialogue discussion on payer expectations:
- What is the impact of changes in Healthcare Policy on payer decision-making process?
- How do health plans interact with employers on formulary decisions and drug utilization?
- What are the preferred mediums of communication and deliverables to payers?
The complexities of the current healthcare landscape and the challenge of proving economic value in today's medicines dominates the responsibilities of senior-level bio/pharma executives involved in strategic reimbursement, managed markets, HEOR and pricing. With a strong agenda offering practical strategies, CBI's Forum on Formulary and Reimbursement Strategies offers valuable insights on current trends and proven methods of ensuring optimal formulary placement and improved market access in today's environment.
For more information, visit http://www.cbinet.com/formulary.
CBI, an Advanstar company, is the leading provider of market-driven, unbiased conferences for the pharmaceutical, biotechnology, medical device and healthcare industries. CBI offers specialized information presented in interactive formats by thought leaders and regulators.
Contact: Kristina Weljkovic
Phone number: 339-298-2285
Email address: [email protected]
This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com.